The Studio at Kendall Square
Episodes
AI Proteins Founder & CEO Chris Bahl and Dana-Farber Cancer Institute Investigator Nick Polizzi discuss the current state of protein design and new innovations that are around the corner
05 Mar 2026
Contributed by Lukas
Both experts in the field, one with an academic view and one from industry, they discuss what can be done today with protein design, new innovations c...
Jack Silberstein's startup, Deck Bio, received a "Golden Ticket" award from Servier - he and Servier's Irene Blat discuss how it is just one of many ways larger companies help biotech entrepreneurs
19 Dec 2025
Contributed by Lukas
Servier's 'Golden Ticket' gave Deck Bio a place to work from at LabCentral and access to Servier's experts for advice. Jack and Irene ...
Precision for Medicine CMO Harpreet Singh and Repertoire Immune Medicines CMO Robert Andtbacka discuss oncology clinical trial design, life on the biotech side, and advice for other CMOs
05 Sep 2025
Contributed by Lukas
In a wide-ranging discussion, Dr. Singh and Dr. Andtbacka reflect on the success of the immunotherapy field and the cancer centers that helped develop...
Two leaders from the Harvard Biotech Club talk about their experience in the club, its new podcast, The Pulse, and an upcoming career fair on September 19th
02 Sep 2025
Contributed by Lukas
Yossef Baidi and Fang Xie describe how getting involved in the club has benefited them, and the idea behind their new podcast (George Church and Peter...
MassBio's CEO Kendalle Burlin O'Connell shares the details of today's just published 2025 Industry Snapshot - a key barometer of the health of biotech not just in Massachusetts, but as an industry
26 Aug 2025
Contributed by Lukas
She discusses the report and specifics on NIH funding, VC investment, jobs, biotech clusters within Massachusetts, and more.
Two experts in genetic medicines, Devan Shah and Michelle Lynn Hall, discuss the recently announced federal funding cuts for mRNA research and what it means for this area of science going forward
18 Aug 2025
Contributed by Lukas
They explain the size and depth of the cuts, and how it will affect research on both respiratory and non-respiratory conditions. Plus, what it means f...
Lisa Deschamps of AviadoBio and Richard Wilson of Astellas discuss the field of AAV gene therapy, and their partnership on AVB-101, an AAV gene therapy for frontotemporal dementia (FTD)
18 Jun 2025
Contributed by Lukas
Lisa and Richard describe the unmet need for frontotemporal dementia and their partnership on AVB-101, which is administered directly to the thalamus....
Biotech veteran Art Krieg explains the science behind his newest immunotherapy company, Zola Therapeutics, which uses both RNA and DNA agonists delivered in an LNP to create broad T-cell responses
22 Apr 2025
Contributed by Lukas
Interviewed by fellow veteran Jim Barsoum, Dr. Krieg shares multi-decade learnings from his previous companies Coley Pharmaceutical Group and Checkmat...
Elias Zerhouni and Andy Plump discuss the future of multispecific biologics
07 Apr 2025
Contributed by Lukas
Interviewed by Andy Plump, President of R&D at Takeda, Dr. Zerhouni discusses the rationale for multispecifics and the science behind them. They a...
Candel Therapeutics CEO Paul Peter Tak and IDEA Pharma CEO Mike Rea on why they believe a different mindset and good communication are keys to succeeding with new innovations in biotech
01 Apr 2025
Contributed by Lukas
They discuss the difference between how biotech companies operate from large pharmas, including how history shows some new biotech innovations faced i...
Korro Bio's Ram Aiyar and Novo Nordisk's Uli Stilz discuss their RNA editing collaboration, the field of genetic medicine, and the future of drug discovery
05 Mar 2025
Contributed by Lukas
Ram Aiyar, President & CEO of Korro Bio, and Uli Stilz, Head of Novo Nordisk's Bio Innovation Hub in Kendall Square, share their backgrounds a...
Devan Shah and Namita Bisaria, experts in the field of RNA therapies, discuss the year ahead in RNA - opportunities, challenges, AI, fundraising, and more
24 Feb 2025
Contributed by Lukas
Devan Shah, Founder & CEO of RNAV8 Bio, and Namita Bisaria, Head of Research, Strategy, and Operations at AIRNA, discusses approaches to RNA they ...
The co-founder of the Scientific Citizenship Initiative discusses the importance of scientific communication, and trying to place STEM PhDs into the Mass. State House as full-time policy advisors
17 Feb 2025
Contributed by Lukas
In a discussion with gene editing technology expert TJ Cradick, Scientific Citizenship Initiative Co-Founder and Co-Director Daniel Pomeroy describes ...
A patient advocacy group founded by two parents has partnered with a biotech company on a gene therapy for limb-girdle muscular dystrophy Type 2C/R5 - it was just cleared to start a clinical trial
19 Nov 2024
Contributed by Lukas
Dion Foundation Co-Founder and President Courtney Dion discusses with Atamyo Therapeutics CEO Stéphane Degove the many ways that patient advocate gro...
Janssen's Elena Diez and Odyssey Therapeutics' Gary Glick share advice on success factors for pharma - biotech partnerships, and more
13 Nov 2024
Contributed by Lukas
They discuss Odyssey's work, the investments it has made regarding in silico and AI/ML tools, the unique value of the Boston biotech ecosystem, an...
Kojin Therapeutics Chairman & CEO Harvey Berger shares an update on the company's progress and talks about the funding environment for earlier stage companies in biotech
25 Oct 2024
Contributed by Lukas
Biotech industry veteran Harvery Berger talks about his company's job at hand to translate the science of ferroptosis into therapies. Plus, a warn...
Transcriptional regulation in disease: opportunities, challenges, and the future
24 Oct 2024
Contributed by Lukas
Cigall Kadoch, associate professor and HHMI Investigator, Dana-Farber Cancer Institute and Harvard Medical School, and scientific founder of Foghorn T...
A father and patient advocate discuss Canavan disease and a daughter's experience on a gene therapy clinical trial
23 Oct 2024
Contributed by Lukas
Lauren Celano, a board member of the National Tay-Sachs & Allied Diseases Association, interviews Lee Greenwood about his family's experience ...
Gene therapy experts TJ Cradick and Andrew Kernytsky discuss the issues surrounding unintended off-target editing of genetic tools like CRISPR
17 Oct 2024
Contributed by Lukas
For this high-tech emerging field within biotech, it is important to get safety right. They discuss the keys to understanding the possible range of ed...
George Church on founder led companies, synthetic biology technologies, the future, and more
07 Oct 2024
Contributed by Lukas
Dan Mandell, Co-Founder and CEO of GRO Biosciences, interviews professor Church about the Genomically Recoded Organisms (GRO) platform that Dan spun o...
Gene therapy experts TJ Cradick and Kate Excoffon discuss using AAV gene therapy for cystic fibrosis
03 Oct 2024
Contributed by Lukas
Dr. Excoffon describes her academic experience that led her to the field and Spirovant Sciences, discusses interesting data from last month’s North ...
Immuno-Oncology experts Zhen Su and Kristen Hege discuss the latest in the field and preview #SITC24
01 Oct 2024
Contributed by Lukas
Dr. Su and Dr. Hege talk about solving the cell therapy solid tumor challenge, the latest in bi-specifics, her recent hike of the Pacific Crest Trail ...